Christopher Dixon

5.2k total citations · 1 hit paper
47 papers, 2.3k citations indexed

About

Christopher Dixon is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Christopher Dixon has authored 47 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Urology, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Rheumatology. Recurrent topics in Christopher Dixon's work include Urinary Bladder and Prostate Research (28 papers), Prostate Cancer Diagnosis and Treatment (20 papers) and Pelvic floor disorders treatments (12 papers). Christopher Dixon is often cited by papers focused on Urinary Bladder and Prostate Research (28 papers), Prostate Cancer Diagnosis and Treatment (20 papers) and Pelvic floor disorders treatments (12 papers). Christopher Dixon collaborates with scholars based in United States, Czechia and France. Christopher Dixon's co-authors include Herbert Lepor, Jack W. McAninch, Robert J. Padley, Michael K. Brawer, William O. Williford, Perinchery Narayan, Thayne R. Larson, Clair Haakenson, Glenn J. Gormley and Lance A. Mynderse and has published in prestigious journals such as New England Journal of Medicine, Radiology and The Journal of Urology.

In The Last Decade

Christopher Dixon

45 papers receiving 2.1k citations

Hit Papers

The Efficacy of Terazosin, Finasteride, or Both in Benign... 1996 2026 2006 2016 1996 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia
    1996 594 citations Herbert Lepor, William O. Williford et al. New England Journal of Medicine profile →

Peers

Christopher Dixon
Gerasimos Alivizatos Greece
Giorgio Bozzini Italy
Kentaro Ichioka Japan
O. Karim United Kingdom
Selçuk Sarıkaya Türkiye
Harry A. Guess United States
J. Steffens Germany
Kamran Zargar‐Shoshtari New Zealand
Yazan Al Salhi Italy
Ahmed Adam South Africa
Gerasimos Alivizatos Greece
Christopher Dixon
Citations per year, relative to Christopher Dixon Christopher Dixon (= 1×) peers Gerasimos Alivizatos

Countries citing papers authored by Christopher Dixon

Since Specialization
Citations

This map shows the geographic impact of Christopher Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Dixon more than expected).

Fields of papers citing papers by Christopher Dixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Dixon. The network helps show where Christopher Dixon may publish in the future.

Co-authorship network of co-authors of Christopher Dixon

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Dixon. A scholar is included among the top collaborators of Christopher Dixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Dixon. Christopher Dixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dixon, Christopher, Richard Levin, Christopher H. Cantrill, et al.. (2022). Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer. Journal of Endourology. 37(2). 225–232. 2 indexed citations
2.
Anderson, Lori, et al.. (2021). Rapid growth of a large penile median raphe cyst. Urology Case Reports. 39. 101864–101864. 1 indexed citations
3.
Tsui, Johnson F. & Christopher Dixon. (2016). Urolift: a New Face of Minimally Invasive Surgical Technique for Benign Prostatic Hyperplasia?. Current Urology Reports. 17(9). 63–63. 3 indexed citations
4.
Roehrborn, Claus G., Steven Gange, Marc Gittelman, et al.. (2016). Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. The Journal of Urology. 197(6). 1507–1516. 89 indexed citations
5.
McVary, Kevin T., Steven Gange, Marc Gittelman, et al.. (2016). Erectile and Ejaculatory Function Preserved with Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. The Journal of Sexual Medicine. 13(6). 924–933. 94 indexed citations
6.
7.
8.
Andrews, Anneliese, et al.. (2009). Classification of hyperactivated spermatozoa using a robust minimum bounding square ratio algorithm. PubMed. 12. 4941–4944. 3 indexed citations
9.
Gómez, Reynaldo, Michael Coburn, Joseph N. Corrieré, et al.. (2004). Consensus statement on bladder injuries. British Journal of Urology. 94(1). 27–32. 168 indexed citations
10.
Djavan, Bob, Alan W. Partin, Michael F. Hoey, et al.. (2000). Transurethral radiofrequency therapy for benign prostatic hyperplasia using a novel saline-liquid conductor: the virtual electrode. Urology. 55(1). 13–16. 8 indexed citations
11.
Chan, Samuel, Christopher Dixon, Samir S. Taneja, et al.. (1999). DETECTION OF CIRCULATING UROPLAKIN-POSITIVE CELLS IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER. The Journal of Urology. 162(3 Part 1). 931–935. 54 indexed citations
12.
Hoey, Michael F., et al.. (1998). Transurethral Prostate Ablation Using Saline-Liquid Electrode Introduced via Flexible Cystoscope. Journal of Endourology. 12(5). 461–468. 12 indexed citations
13.
Lepor, Herbert, et al.. (1997). Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Urology. 49(3). 476–480. 33 indexed citations
14.
Lepor, Herbert, William O. Williford, Michael J. Barry, et al.. (1996). The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia. New England Journal of Medicine. 335(8). 533–540. 594 indexed citations breakdown →
15.
Dixon, Christopher, et al.. (1995). Evaluating the Cost of Lasers for the Treatment of Benign Prostatic Hyperplasia. Journal of Endourology. 9(2). 189–193. 6 indexed citations
16.
Kabalin, John N., Stacy J. Childs, Herbert Lepor, et al.. (1995). A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology. 46(2). 155–160. 124 indexed citations
17.
Dixon, Christopher. (1995). Evaluating the efficacy, safety, and cost of lasers for the treatment of benign prostatic hyperplasia. World Journal of Urology. 13(2). 130–3. 5 indexed citations
18.
Lepor, Herbert, et al.. (1994). Perianastomotic injection of autologous fat at the time of radical retropubic prostatectomy. Urology. 44(5). 783–788. 9 indexed citations
19.
Petrovich, Zbigniew, Filip Ameye, Luc Baert, et al.. (1993). New Trends in the Treatment of Benign Prostatic Hyperplasia and Carcinoma of the Prostate. American Journal of Clinical Oncology. 16(3). 187–200. 14 indexed citations
20.
Narumi, Y, Hedvig Hricak, Noel A. Armenakas, Christopher Dixon, & J W McAninch. (1993). MR imaging of traumatic posterior urethral injury.. Radiology. 188(2). 439–443. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerasimos Alivizatos Breakdown of academic impact, for papers by Giorgio Bozzini Breakdown of academic impact, for papers by Kentaro Ichioka Breakdown of academic impact, for papers by O. Karim Breakdown of academic impact, for papers by Selçuk Sarıkaya Breakdown of academic impact, for papers by Harry A. Guess Breakdown of academic impact, for papers by J. Steffens Breakdown of academic impact, for papers by Kamran Zargar‐Shoshtari Breakdown of academic impact, for papers by Yazan Al Salhi Breakdown of academic impact, for papers by Ahmed Adam
Rankless by CCL
2026